Psychiatry and Neurology, Neurology · Phoenix, AZ
NPI
1508822974
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
515 W Buckeye Rd, Ste 208
Phoenix, AZ, 85003
Phone (602) 258-3305
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
223 services
Medicare patients, 2024
99
Average age 74
Drug cost, 2024
$960K
2,801 prescriptions
Company payments, 2025
$35K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victor H Salazar-Calderon was code 99214 (office e&m - established), 155 times for 77 patients. In total Victor H Salazar-Calderon billed 223 services in 10 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 155 | 77 | $74.95 | $12K |
| 99205 Office E&M - New | Office | 28 | 28 | $147.86 | $4,140 |
By year: 2022 $21K for 235 services; 2023 $18K for 207 services; 2024 $20K for 223 services.
Medicare prescription drug claims, 2024
In 2024, the drug Victor H Salazar-Calderon prescribed most often to Medicare patients was Donepezil Hcl, with 389 prescriptions and refills. In total Victor H Salazar-Calderon wrote 2,801 Medicare prescriptions that cost $960K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 389 | 1,088 | 156 | $4,140 |
| Levetiracetam Generic | 196 | 414 | 41 | $8,417 |
| Divalproex Sodium Er Divalproex Sodium | 160 | 401 | 54 | $19K |
| Namzaric Memantine Hcl/Donepezil Hcl | 148 | 405 | 51 | $245K |
| Escitalopram Oxalate Generic | 141 | 390 | 52 | $1,193 |
| Memantine Hcl Generic | 133 | 375 | 57 | $5,222 |
| Quetiapine Fumarate Generic | 95 | 171 | 30 | $1,294 |
| Zonisamide Generic | 91 | 148 | 13 | $4,616 |
| Briviact Brivaracetam | 87 | 87 | Under 11 | $140K |
| Gabapentin Generic | 80 | 190 | 26 | $2,130 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 76 | 201 | 25 | $1,895 |
| Lacosamide Generic | 64 | 70 | Under 11 | $4,912 |
| Topiramate Generic | 58 | 164 | 20 | $494 |
| Phenytoin Sodium Extended Generic | 55 | 108 | 13 | $1,977 |
| Qulipta Atogepant | 52 | 54 | Under 11 | $62K |
Brand drugs: 499 claims; generic drugs: 2,281 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victor H Salazar-Calderon $35K ($35K in general payments such as food, travel and fees) from 12 companies. The largest payer was Axsome Therapeutics, Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 15 | $21K |
| Abbvie Inc. ABBV | 31 | $12K |
| ACADIA Pharmaceuticals Inc ACAD | 21 | $301 |
| Amgen Inc. AMGN | 2 | $265 |
| Medtronic, Inc. MDT | 2 | $243 |
| Inspire Medical Systems, Inc. INSP | 1 | $145 |
| Madrigal Pharmaceuticals MDGL | 1 | $126 |
| Novo Nordisk Inc NVO | 1 | $125 |
| Eisai Inc. 4523.T | 1 | $122 |
| Abbott Laboratories ABT | 1 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.